Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma Limited has filed its financial results for the period ending March 31, 2025, with the stock exchange. This typically covers Q4 FY25 and full-year FY25 performance. The filing marks the company's compliance with quarterly/annual disclosure requirements under listing norms. Specific revenue, profit, and margin figures are not included in the headline and would be available in the detailed results document.
The filing itself is a routine regulatory submission and does not move the stock. Investors should review the detailed results for revenue growth, profit trends, and margin performance to gauge the company's actual financial health.